Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bundamedik Tbk (BMHS) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance

Bundamedik TbkTrade
Charlie Hospital Semarang Tbk.Trade

Price performance (Past 24H)

Key statistics

Bundamedik Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Bundamedik Tbk is far larger — about 2.1× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 536.7K). Which is the better fit depends on your goals.

BMHSRSCH
Market Cap
1.51T715.5B
Volume
536.7K30.64M
Lot
5.37K306.41K
Turnover
93.41M7.98B
Average Price
174.05260.34
Value
93.41M7.98B
Indicative Equilibrium Price
176256
Indicative Equilibrium Volume
100512

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMHS
View details
RSCH
View details

About Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Read more on BMHS

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH